A new international consortium to promote Stem Cell-Based Therapy for Huntington's disease
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) thro...
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) thro...
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity...
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumo...
This February, the projects awarded in the latest call for applications of the Horizon 2020 FET Open program on research and innovation actions (FE...
The University of Barcelona, Hospital Clínic and the pharmaceutical company AstraZeneca created the UB-Hospital Clínic Chair on Lung Cancer AstraZe...
Anaphylaxis is a systemic allergic reaction that can affect the skin, the gastrointestinal tract, the respiratory system and the cardiovascular sys...
A study published in the journal Science and coordinated by researchers of IDIBAPS and the UB describes a new immune defence mechanism unknown unti...
Researchers of IDIBAPS have participated in an interdisciplinary research study of the UB in which there have been identified two potential candida...
Researchers from the Respiratory biophysics and bioengineering IDIBAPS research group, the Biophysics and Bioengineering Unit of the UB and the CIB...
A team formed by professionals from Hospital Clínic, Germans Trias i Pujol Research Institute and Hospital (IGTP) and the Faculty of Medicine and H...